With the increase in recombinant therapeutic proteins expressed by CHO cells, CLD is now a major bottleneck in acquiring cell traces for production. The basic ideas for CLD involve preliminary screening for prime-generate cell pool, solitary-cell isolation and improvement of productivity, clonality and security. With the development of modern Exami